Form 4 holding
Director
Celldex Therapeutics, Inc.
- Security class
- Non-Qualified Stock Option (right to buy)
- Shares / value
- 16,500
- Estimated value
- Report date
- 13 Jun 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount